Translocation of bacterial DNA from Gram-positive microorganisms is associated with a species-specific inflammatory response in serum and ascitic fluid of patients with cirrhosis

Clinical and Experimental Immunology

Volumn 150, Issue 2, 2007, Pages 230-237

  Frances R ^a,b   Gonzalez Navajas J M ^a,b   Zapater, P ^a,b   Munoz C ^b   Cano R ^b   Pascual, S ^a,b   Santana, F ^b   Marquez D ^b   Perez Mateo M ^b   Such, J ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Ascitic fluid; Bacterial DNA; Cirrhosis; Cytokines; NF B

Indexed keywords

BACTERIAL DNA; CYTOKINE; CYTOSINE; GUANOSINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ARTICLE; ASCITES FLUID; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; INNATE IMMUNITY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPECIES DIFFERENCE; STATISTICAL SIGNIFICANCE;

AGED; ASCITIC FLUID; BACTERIAL TRANSLOCATION; DNA, BACTERIAL; FEMALE; GRAM-POSITIVE BACTERIA; HUMANS; INFLAMMATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEUTROPHILS; NF-KAPPA B; PROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TH1 CELLS;

EID: 35349016366     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03494.x     Document Type: Article

References (41)

1. Such J, Frances R, Munoz C et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology 2002 36 : 135 41.
2. Frances R, Benlloch S, Zapater P et al. A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. Hepatology 2004 39 : 484 91.
3. Guarner C, Gonzalez-Navajas JM, Sanchez E et al. The detection of bacterial DNA in blood of rats with CCl(4)-induced cirrhosis with ascites represents episodes of bacterial translocation. Hepatology 2006 44 : 633 9.
4. Frances R, Munoz C, Zapater P et al. Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut 2004 53 : 860 4.
5. Frances R, Rodriguez E, Munoz C et al. Intracellular cytokine expression in peritoneal monocyte/macrophages obtained from patients with cirrhosis and presence of bacterial DNA. Eur J Gastroenterol Hepatol 2005 17 : 45 51.
6. Frances R, Gonzalez-Navajas JM, Zapater P et al. Soluble mediators engagement by bacterial DNA in cirrhotic patients with culture-negative ascitic fluid. Hepatology 2006 44 (Suppl. 1 461A.
7. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998 27 : 669 74.
8. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000 408 : 740 5.
9. Wagner H. Toll meets bacterial CpG-DNA. Immunity 2001 14 : 499 502.
10. Chuang TH, Lee J, Kline L, Mathison JC, Ulevitch RJ. Toll-like receptor 9 mediates CpG-DNA signaling. J Leukoc Biol 2002 71 : 538 44.
11. Dalpke A, Frank J, Peter M, Heeg K. Activation of Toll-like receptor 9 by DNA from different bacterial species. Infect Immun 2006 74 : 940 6.
12. Krieg AM, Yi AK, Matson S et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995 374 : 546 9.
13. Bauer S, Kirschning CJ, Hacker H et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001 98 : 9237 42.
14. Such J, Hillebrand DJ, Guarner C et al. Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection. Dig Dis Sci 2001 46 : 2360 6.
15. Navasa M, Follo A, Filella X et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998 27 : 1227 32.
16. Lopez-Talavera JC, Merrill WW, Groszmann RJ. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 1995 108 : 761 7.
17. Frances R, Chiva M, Sanchez E et al. Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites. J Hepatol 2007 46 : 797 803.
18. Zapater P, Frances R, Gonzalez-Navajas JM et al. Ascitic and serum bacterial DNA is a short-term survival indicator in patients with cirrhosis and culture-negative, non-neutrocytic ascites. Gastroenterol Hepatol 2006 29 (Suppl. 1 117.
19. Albillos A, Cuervas-Mons V, Millan I et al. Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology 1990 98 : 134 40.
20. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995 273 : 117 23.
21. Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med 1986 146 : 2259 61.
22. Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988 95 : 1351 5.
23. Roth RI, Levin FC, Levin J. Optimization of detection of bacterial endotoxin in plasma with the Limulus test. J Lab Clin Med 1990 116 : 153 61.
24. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002 20 : 709 60.
25. Hacker H. Signal transduction pathways activated by CpG-DNA. Curr Top Microbiol Immunol 2000 247 : 77 92.
26. Iho S, Yamamoto T, Takahashi T, Yamamoto S. Oligodeoxynucleotides containing palindrome sequences with internal 5′-CpG-3′ act directly on human NK and activated T cells to induce IFN-gamma production in vitro. J Immunol 1999 163 : 3642 52.
27. Lipford GB, Sparwasser T, Bauer M et al. Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur J Immunol 1997 27 : 3420 6.
28. Sparwasser T, Miethke T, Lipford G et al. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol 1997 27 : 1671 9.
29. Cowdery JS, Chace JH, Yi AK, Krieg AM. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J Immunol 1996 156 : 4570 5.
30. Martin-Orozco E, Kobayashi H, Van Uden J, Nguyen MD, Kornbluth RS, Raz E. Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences. Int Immunol 1999 11 : 1111 18.
31. Sparwasser T, Koch ES, Vabulas RM et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 1998 28 : 2045 54.
32. Fernandez J, Navasa M, Gomez J et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002 35 : 140 8.
33. Guarner C, Soriano G, Tomas A et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993 18 : 1139 43.
34. Krieg AM. CpG motifs: the active ingredient in bacterial extracts? Nat Med 2003 9 : 831 5.
35. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 1997 186 : 1623 31.
36. Roman M, Martin-Orozco E, Goodman JS et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997 3 : 849 54.
37. Lipford GB, Bauer M, Blank C, Reiter R, Wagner H, Heeg K. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur J Immunol 1997 27 : 2340 4.
38. Sester DP, Naik S, Beasley SJ, Hume DA, Stacey KJ. Phosphorothioate backbone modification modulates macrophage activation by CpG DNA. J Immunol 2000 165 : 4165 73.
39. Roberts TL, Dunn JA, Terry TD et al. Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotides. J Immunol 2005 175 : 3569 76.
40. Gao JJ, Zuvanich EG, Xue Q, Horn DL, Silverstein R, Morrison DC. Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264·7 macrophages. J Immunol 1999 163 : 4095 9.
41. Frances R, Gonzalez-Navajas JM, Zapater P et al. Bacterial DNA induces the complement system activation in serum and ascitic fluid from patients with advanced cirrhosis. J Clin Immunol 2007 27 : 438 44.